Insider Trading Summary for Neurocrine Biosciences Inc. (NBIX): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
20-Nov-23 4:10 PM View:	16-Nov-23 Gift 0	Sherwin Stephen A Director		Neurocrine Biosciences Inc. - NBIX	(11%) 25.05K to 22.3K	0	0	--	--	Show Txns Hide Txns

15-Mar-24 5:19 PM View:	13-Mar-24 Planned Option Sale ($3.26M)	Pops Richard F Director		Neurocrine Biosciences Inc. - NBIX	0% 29.51K	0	0	--	--	Show Txns Hide Txns

27-Dec-23 4:10 PM View:	22-Dec-23 Private Sale (Planned) ($1.30M)	Lyons Gary A Director		Neurocrine Biosciences Inc. - NBIX	(53%) 412.39K to 193.7K	0	0	--	--	Show Txns Hide Txns

04-Jan-24 6:26 PM View:	02-Jan-24 Planned Option Sale ($1.45M)	Rastetter William H Director		Neurocrine Biosciences Inc. - NBIX	31% 39.46K to 51.74K	0	0	--	--	Show Txns Hide Txns

15-Feb-24 5:45 PM View:	13-Feb-24 Private Sale (Planned) ($146.03K)	Lippoldt Darin Chief Legal Officer		Neurocrine Biosciences Inc. - NBIX	(19%) 49.12K to 39.74K	0	0	--	--	Show Txns Hide Txns

17-Apr-24 5:19 PM View:	15-Apr-24 Planned Private Option Sale ($2.64M)	Benevich Eric Chief Commercial Officer		Neurocrine Biosciences Inc. - NBIX	7% 38.04K to 40.78K	0	0	--	--	Show Txns Hide Txns

15-Mar-24 5:25 PM View:	14-Mar-24 Planned Option Sale ($5.58M)	Morrow George J Director		Neurocrine Biosciences Inc. - NBIX	0% --	0	0	--	--	Show Txns Hide Txns

15-Feb-24 5:40 PM View:	13-Feb-24 Private Sale (Planned) ($179.67K)	Gano Kyle Chief Business Development Off		Neurocrine Biosciences Inc. - NBIX	2% 132.38K to 135.17K	0	0	--	--	Show Txns Hide Txns

15-Feb-24 5:43 PM View:	13-Feb-24 Private Sale (Planned) ($376.70K)	Gorman Kevin Charles Chief Executive Officer Director		Neurocrine Biosciences Inc. - NBIX	1% 509.08K to 514.6K	0	0	--	--	Show Txns Hide Txns

15-Feb-24 5:27 PM View:	13-Feb-24 Private Sale (Planned) ($179.61K)	Abernethy Matt Chief Financial Officer		Neurocrine Biosciences Inc. - NBIX	8% 29.26K to 31.53K	0	0	--	--	Show Txns Hide Txns

15-Feb-24 5:51 PM View:	13-Feb-24 Private Sale (Planned) ($148.12K)	Roberts Eiry Chief Medical Officer		Neurocrine Biosciences Inc. - NBIX	(28%) 32.72K to 23.72K	0	0	--	--	Show Txns Hide Txns

15-Feb-24 5:35 PM View:	13-Feb-24 Private Sale (Planned) ($105.90K)	Cooke Julie Chief Human Resources Officer		Neurocrine Biosciences Inc. - NBIX	(35%) 27.57K to 17.98K	0	0	--	--	Show Txns Hide Txns

29-Feb-24 6:50 PM View:	27-Feb-24 Planned Option Sale ($1.09M)	Norwalk Leslie V Director		Neurocrine Biosciences Inc. - NBIX	0% --	0	0	--	--	Show Txns Hide Txns

15-Feb-24 5:48 PM View:	13-Feb-24 Private Sale (Planned) ($190.37K)	Onyia Jude Chief Scientific Officer		Neurocrine Biosciences Inc. - NBIX	2% 12.84K to 13.13K	0	0	--	--	Show Txns Hide Txns

15-Feb-24 5:33 PM View:	13-Feb-24 Private Sale (Planned) ($241.00K)	Boyer David W. Chief Corp. Affairs Officer		Neurocrine Biosciences Inc. - NBIX	(37%) 7.79K to 4.89K	0	0	--	--	Show Txns Hide Txns

03-Apr-24 4:44 PM View:	01-Apr-24 Planned Private Option Sale ($37.35K)	Delaet Ingrid Chief Regulatory Officer		Neurocrine Biosciences Inc. - NBIX	24% 6.05K to 7.51K	0	0	--	--	Show Txns Hide Txns

Neurocrine Biosciences Inc. (NBIX)

Last Year

27-Apr-23 -- 26-Apr-24

Company Sentiment

Biotechnology

Drugs

Two Year Chart

27-Apr-22 -- 26-Apr-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Buy:	0	--
Sell:	0	--